✨
AI Summary
- Integrating emerging molecular biomarkers into clinical practice discussed.
- Personalizing treatment decisions in prostate cancer.
- Barriers to precision oncology are highlighted.
Guests on This Episode
JM
Joshua Lang, MD, MS
1 podcast appearance